Top 10 research priorities for irritable bowel syndrome: results of a James Lind Alliance priority setting partnership
- PMID: 36996852
- DOI: 10.1016/S2468-1253(23)00072-9
Top 10 research priorities for irritable bowel syndrome: results of a James Lind Alliance priority setting partnership
Conflict of interest statement
The James Lind Alliance priority setting partnership dealing with the diagnosis, treatment, and care of people with IBS was funded equally by Guts UK Charity and the British Society of Gastroenterology. We thank all the people with IBS, family members, carers, and health-care professionals who took part in this priority setting partnership, including the final workshop. ACF has received grants from Tillotts Pharma, consulting fees from Ironwood, and payment or honoraria for webinars from GE Healthcare and Sandoz. All other authors declared no competing interests.